Trial site
The Second Affiliated Hospital of Kunming Medical University
- 34running trials
- 24closed trials
The trials here
What the 58 trials at this site are about, from their registry records.
- Conditions
- Haemophilia13 trials
- Immune thrombocytopenia (ITP)6 trials
- Stroke4 trials
- Acute myeloid leukaemia3 trials
- Atrial fibrillation3 trials
- Bladder cancer3 trials
- Liver cirrhosis3 trials
- Lung cancer3 trials
- Psoriasis3 trials
- Colorectal cancer2 trials
- Migraine2 trials
- Myeloproliferative neoplasms2 trials
- and 15 more
- Phase
- Phase 332 trials
- Phase 2/36 trials
- Phase 1/25 trials
- Phase 23 trials
- Phase 43 trials
- Phase 12 trials
- Status
- Completed23 trials
- Active, not recruiting13 trials
- Recruiting11 trials
- Not yet recruiting10 trials
- Terminated1 trial
- Lead sponsor
- Hangzhou Gensciences Biopharmaceutical Co., Ltd.4 trials
- Novo Nordisk A/S3 trials
- Sun Yat-sen University3 trials
- Takeda3 trials
- The Second Affiliated Hospital of Kunming Medical University3 trials
- and 38 more
Running trials
Not yet recruiting
Not yet recruiting
Intraosseous Tranexamic Acid for Reducing Blood Loss in Total Knee Arthroplasty
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment
Recruiting
DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Recruiting
Recruiting
To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A
Active, not recruiting
Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients
Recruiting
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
Recruiting
Active, not recruiting
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
Recruiting
Recruiting
Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Active, not recruiting
Recruiting
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Immune thrombocytopenia (ITP)3 recruiting
- Atrial fibrillation2 recruiting
- Bladder cancer2 recruiting
- Haemophilia2 recruiting
- Prostate cancer2 recruiting
- Stroke2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Brain aneurysm1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Heart failure1 recruiting
- Liver cirrhosis1 recruiting
- Lung cancer1 recruiting
- Osteoarthritis1 recruiting
- Primary biliary cholangitis1 recruiting
Closed trials
Completed
Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Completed
Completed
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Completed
Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
Completed
Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor
Completed
Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein
Completed
Completed
Completed
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
Completed
Completed
Completed
Completed
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026